REYNDERS label printing
Is this your company? Claim this profile
Drug Product
Company Overview
About
REYNDERS label printing is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Neurology
Quick Facts
HQ:Belgium
Founded:2015
Employees:941
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
North America
Regulatory Approvals
Drug Approval DYW3AM
PMDA · #APR-KNIIOQNU · 2022-04-01
Drug Approval R4LDJA
PMDA · #APR-F8RX6HOG · 2022-05-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-W0C5FQZW
Issued: 2020-09-12
Expires: 2025-08-21
Health Canada GMP
Health Canada
Cert #: CERT-906MXAW6
Issued: 2020-05-06
Expires: 2025-09-25
Loading CDMO intelligence...
Key facts about REYNDERS label printing
- REYNDERS label printing is headquartered in Belgium.
- REYNDERS label printing was founded in 2015.
- REYNDERS label printing has 941 employees.
- REYNDERS label printing's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like REYNDERS label printing
Directory pages this company appears in, each with the full list of matching manufacturers.